Enlivex Announces Issuance of New European Patent Covering Therapeutic Compositions of Allocetra and CAR-T Immunotherapies for Inhibition or Reduction of Cytokine Storms Associated with CAR-T Therapies for Cancer
Nes-Ziona, Israel, June 15, 2021 (GLOBE NEWSWIRE) — – Enlivex Therapeutics Ltd., (Nasdaq: ENLV, the…